Twitter Facebook LinkedIn
Center for Global Research Data

How to share your clinical research data on the Vivli COVID-19 Portal

Steps to sharing your COVID-19 clinical research data on Vivli

1. Please fill out the information request at the bottom of this page.
2. Vivli will then email you the Data Contribution Form and the Data Contributor Agreement (DCA) that needs to be read, understood and signed by the Principal Investigator and an institution official via DocuSign.
3. Once this information is complete, Vivli will inform you when your clinical research data is listed on the Vivli COVID-19 portal and share with you the DOI to include in any publications.
4. Vivli will reach out to you when you are close to having data ready to share to get it loaded into the platform. If you need help with anonymization, Vivli will connect you to specialists in this area who will waive their fees to support your efforts.

What do I need to share as part of my data package?

Data package – Protocol, anonymized individual participant-level dataset, data dictionary, and statistical analysis plan are recommended; additional elements such as an annotated case report forms, clinical study report, and analysis ready datasets can also be included.

Is there a cost associated with sharing?

Vivli will waive all fees associated with the sharing, archiving and requesting of your COVID-19 trials.

When should I share?

Given the urgency of the global pandemic, we would recommend that you should plan how to share your data as soon as you can. Work with the Vivli team to list your studies, sign all legal agreements and the target for when the data will be available. Then we will work with you nearer to the time to upload your anonymized data for sharing into the Vivli COVID-19 portal.

What is the review process?

When a research team requests your study, an Accelerated Research Proposal review will be conducted within 3 business days. Vivli will manage the execution of the Data Use Agreement. Once these steps are completed, the Vivli team will work with the researcher to access the data and support them until they have published their results.

If you or your organization has clinical research data from a COVID-19 related trial to share or wish to connect with Vivli on how your organization can help, please get in touch with us in filling out the form below and we will respond shortly.

Here are some additional links to groups working on pulling together resources and guidelines in relation to COVID-19.

 RDA COVID-19 Working Group. recommendations and guidelines. Research Data Alliance.